SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Pluri Inc. (PLUR) (CIK 0001158780) (PLUR) — May 12, 2011

Pluri Inc. (PLUR) (CIK 0001158780)
Date: May 12, 2011 · CIK: 0001158780 · Accession: 0000000000-11-029728

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-31392

Date
May 11, 2011
Author
Joel Parker
Form
UPLOAD
Company
Pluri Inc. (PLUR) (CIK 0001158780)

Letter

May 11, 2011 Yaky Yanay Chief Financial Officer (Principal Financial and Accounting Officer) Pluristem Therapeutics, Inc. MATAM Advanced Technology Park Building No. 20 Haifa, Israel 31905

Re: Pluristem Therapeutics, Inc Form 10-K for Fiscal Year Ended June 30, 2010 Filed September 21, 2010 File No. 001-31392

Dear Mr. Yanay:

We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not fore close the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely,

Joel Parker Accounting Branch Chief

Show Raw Text
May 11, 2011

Yaky Yanay
Chief Financial Officer
(Principal Financial and Accounting Officer)
Pluristem Therapeutics, Inc. MATAM Advanced Technology Park Building No. 20
Haifa, Israel 31905

Re: Pluristem Therapeutics, Inc
 Form 10-K for Fiscal Year Ended June 30, 2010
  Filed September 21, 2010
   File No.  001-31392

Dear Mr. Yanay:

We have completed our review of your f iling.  We remind you that our comments or
changes to disclosure in res ponse to our comments do not fore close the Commission from taking
any action with respect to the company or th e filing and the company may not assert staff
comments as a defense in any proceeding ini tiated by the Commission or any person under the
federal securities laws of the United States.  We urge all pers ons who are responsible for the
accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.
 Sincerely,

Joel Parker Accounting Branch Chief